The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of Cobas 4800 BRAF mutation test for the analysis of BRAF V600 mutations in cytological samples (CS) from metastatic melanoma (MM).
Salvador Martin-Algarra
Consultant or Advisory Role - Roche
Research Funding - Roche
Tania Labiano
No relevant relationships to disclose
Jose Ignacio Echeveste
No relevant relationships to disclose
Nerea Gomez
No relevant relationships to disclose
Myriam Montañana
No relevant relationships to disclose
Mercedes Aguirre
No relevant relationships to disclose
Mari­a Eugenia Echarri
No relevant relationships to disclose
Miguel F. Sanmamed
No relevant relationships to disclose
Alfonso Gurpide
No relevant relationships to disclose
Jose Luis Perez-Gracia
No relevant relationships to disclose
Miguel A. Idoate
No relevant relationships to disclose
Maria D. Lozano
Consultant or Advisory Role - Roche (I)
Research Funding - Roche (I)